Not Applicable
Not Applicable
A stent is a medical device introduced to a body lumen and is well known in the art. Typically, a stent is implanted in a blood vessel at the site of a stenosis or aneurysm endoluminally, i.e. by so-called “minimally invasive techniques” in which the stent in a radially reduced configuration, optionally restrained is a radially compressed configuration by a sheath and/or catheter, is delivered by a stent delivery system or “introducer” to the site where it is required. The introduce may enter the body from an access location outside the body, such as through the patient's skin, or by a “cut down” technique in which the entry blood vessel is exposed by minor surgical means.
Stents, grafts, stent-grafts, vena cava filters, expandable frameworks, and similar implantable medical devices are radially expandable endoprostheses which are typically intravascular implants capable of being implanted transluminally and enlarged radially after being introduced percutaneously. Stents may be implanted in a variety of body lumens or vessels such as within the vascular system, urinary tracts, bile ducts, fallopian tubes, coronary vessels, secondary vessels, etc. They may be self-expanding, expanded by an internal radial force, such as when mounted on a balloon, or a combination of self-expanding and balloon expandable (hybrid expandable).
Stents may be created by methods including cutting or etching a design from a tubular stock, from a flat sheet which is cut or etched and which is subsequently rolled or from one or more interwoven wires or braids.
Within the vasculature, it is not uncommon for stenoses to form at a vessel bifurcation. A bifurcation is an area of the vasculature or other portion of the body where a first (or parent) vessel is bifurcated into two or more branch vessels. Where a stenotic lesion or lesions form at such a bifurcation, the lesion(s) can affect only one of the vessels (i.e., either of the branch vessels or the parent vessel) two of the vessels, or all three vessels. Many prior art stents however are not wholly satisfactory for use where the site of desired application of the stent is juxtaposed or extends across a bifurcation in an artery or vein such, for example, as the bifurcation in the mammalian aortic artery into the common iliac arteries.
The art referred to and/or described above is not intended to constitute an admission that any patent, publication or other information referred to herein is “prior art” with respect to this invention. In addition, this section should not be construed to mean that a search has been made or that no other pertinent information as defined in 37 C.F.R. §156(a) exists.
All US patents and applications and all other published documents mentioned anywhere in this application are incorporated herein by reference in their entirety.
Without limiting the scope of the invention a brief summary of some of the claimed embodiments of the invention is set forth below. Additional details of the summarized embodiments of the invention and/or additional embodiments of the invention may be found in the Detailed Description of the Invention below.
In at least one embodiment, a stent comprises a first section comprising plurality of interconnected framework members defining a plurality of potential side branches. In some embodiments, each of the plurality of potential side branches has the same configuration. In some embodiments, the plurality of potential side branches has a plurality of configurations. In at least one embodiment, the plurality of interconnected framework members comprises at least four serpentine rings and a plurality of connecting members.
In at least one embodiment, the stent further comprises a second section comprising at least one circumferential band of struts, the second section engaged to the first section by at least one connector.
In at least one embodiment, a delivery system comprises a balloon catheter having a dual lumen balloon and a stent disposed about the dual lumen balloon. In some embodiments, the dual lumen balloon has an inner balloon made of non-complaint material and an outer balloon made of compliant material. In other embodiments, the inner balloon is in fluid communication with an inner inflation lumen and the outer balloon is in fluid communication with an outer inflation lumen.
In at least one embodiment, a delivery system comprises a balloon catheter having a balloon that progressively inflates from the proximal end to the distal end.
In at least one embodiment, a delivery system comprises a balloon having a plurality of protrusions or herniations with a stent disposed about the balloon. In some embodiments, at least one of the plurality of protrusions or herniations deploys at least one side branch of the stent disposed about the balloon.
These and other embodiments which characterize the invention are pointed out with particularity in the claims annexed hereto and forming a part hereof. However, for further understanding of the invention, its advantages and objectives obtained by its use, reference can be made to the drawings which form a further part hereof and the accompanying descriptive matter, in which there is illustrated and described an embodiments of the invention.
A detailed description of the invention is hereafter described with specific reference being made to the drawings.
a-g are examples of different configurations for the undulating member and the side branch opening defined by the undulating member.
While this invention may be embodied in many different forms, there are described in detail herein specific embodiments of the invention. This description is an exemplification of the principles of the invention and is not intended to limit the invention to the particular embodiments illustrated.
For the purpose of this disclosure, like reference numerals in the figures shall refer to like features unless otherwise indicated. Note that identifiers, e.g. a, used in FIGS. 1 and 3-4 are not intended to be the same in
Although the figures in this application show the stent 10 in a flat, plan view, in use, the stent 10 has a tubular body. The wall of the tubular body has curvature, therefore the members forming the tubular body, e.g. struts 24, serpentine members 40 etc., have the same curvature as the wall of the tubular body. In addition, the cells 70 defined by the members of the tubular body also have curvature because the cells 70 are defined by the wall of the stent 10.
As used in the application, the terms serpentine, undulating and zig-zag describe a winding course or pathway. Thus, a pathway with plurality of turns is undulating, serpentine or zig-zag. The turns of the pathway can be sharp, curved, and any combination thereof.
In the stent embodiments shown in
The middle section 18 of the stent 10 in
As shown in
In at least one embodiment, the middle section 18 of the stent 10 comprises a plurality of undulating or serpentine rings/members 40 and a plurality of connecting members 90. In
In some embodiments, at least one of the potential side branches 68 is in a deployed state. Thus, the stent 10 in this embodiment is a bifurcated stent 10. In other embodiments, none of the plurality of potential side branches 68 are in a deployed state. Thus, the stent 10 in this embodiment is a non-bifurcated stent 10.
Each potential side branch 68 has a configuration.
In some embodiments, all the potential side branches 68 have the same configuration, as shown for example in
The first potential side branch 68a in
In at least one embodiment, the undulating member 40 comprises alternating petals 41a and linking members 42. As shown in
In some embodiments, the linking member 42 comprises a plurality of second petals 41b. In this embodiment, each of the second petals 41 is partially defined by a second inner turn 46b. As shown in
In some embodiments, the plurality of members 50 comprises a plurality of fast members 52 and a plurality of second members 54. It is within the scope of the invention for the first and second members 52,54 to be either straight or to have at least one bend 57. In some embodiments, the first and second members 52,54 have different lengths, as shown, for example, in
As shown in
In at least one embodiment, the undulating member 40 comprises a plurality of sections, each section comprising the following sequence of elements: a petal 41 (the petal 41 comprising a primary inner turn), a primary first member 52, a primary outer turn 48, a primary second member 54, a secondary inner turn 46b, a secondary second member 54, a secondary outer turn 48, and a secondary first member 52. The sections are arranged so that the first member 52 of one section is engaged to the petal 41 of the adjacent section. Although the undulating member 40 in
In at least one embodiment, the undulating member 40 comprises a plurality of sections, each section comprising the following sequence of elements: a first petal 41a (the first petal 41a comprising a primary inner turn 46a), a primary first member 52, a primary outer turn 48, a primary second member 54, a second petal 41b (the second petal 41b comprising a secondary inner turn 46b), a secondary second member 54, a secondary outer turn 48, and a secondary first member 52. The sections are arranged so that the first member 52 of one section is engaged to the first petal 41a of the adjacent section.
In some embodiments, the undulating member 40 can be described in relation to the center point 74 of a center region 72 of the side branch opening 70, as shown in
Because the reference circles C1, C2 and C3 are centered upon the center point 74, reference circles C1, C2 and C3 are concentric circles. In some embodiments, the same distance separates adjacent reference circles C1, C2 and C3. Thus, the distance between C1 and C2 is the same as the distance between C2 and C3. In some embodiments, the distance between C1 and C2 is greater than the distance between C2 and C3. In some embodiments, the distance between C1 and C2 is smaller than the distance between C2 and C3. Note that when the flat pattern shown in the figures is in the shape of a tubular stent 10, the reference circles (C1, C2 and C3) will be convex due to the curved surface of the tubular stent 10.
The undulating member 40 of the potential side branch 68a defines a first side branch opening 70a In this embodiment, the side branch opening 70a has a center region 72, with a center point 74, firm which six regions 75 extend. The regions 75 in this embodiment can be described as bident, as shown for example, in
As shown in
In at least one embodiment, the first and second arms 76a,b of the region 75 are parallel to one another, as shown, for example in
In this embodiment, the six regions 75 form three pairs of regions 75, with each pair of legions 75 on an axis (A1, A2 and A3) to the longitudinal axis (L) of the stent 10, as shown in
As shown in
In some embodiments, the connecting member 90 is engaged to the petal 41, as shown for example in
As shown in
A second potential side branch configuration 68b is shown in
In some embodiments, both second side branch openings 70b and 70c are defined by alternating connecting members 90 and portions of undulating members 40, defining the regions 75 of the first side branch configuration 68a In this embodiment, side branch opening 70b is defined by connecting member 90a, a portion of undulating member 40a, connecting member 90b, a portion of undulating member 40b, connecting member 90c and a portion of undulating member 40c. Similarly, side branch opening 70c is defined by connecting member 90b, a portion of undulating member 40a, connecting member 90d, a portion of undulating member 40d, connecting member 90e and a portion of undulating member 40b. Thus, one connecting member 90, connecting member 90b, defines a portion of both side branch openings 70b and 70b. In addition, a first portion of undulating member 40a defines a portion of side branch opening 70b and second portion of undulating member 40a defines a portion of side branch opening 70c. Similarly, a first portion of undulating member 40b defines a portion of side branch opening 70b and a second portion of undulating member 40b defines a portion of side branch opening 70c.
In this embodiment, side branch openings 70b and 70c each have a center region 72, a first arm 76a, a second arm 76b, a third arm 76c, a first irregular shaped region 80a, a second irregular shaped region 80b, and a third irregular shaped region 80c, as shown in
In some embodiments, petals 41 are disposed about the center region 72 of the second potential side branch 68b/c. As shown in
In some embodiments, the second side branch configuration 68b/c can be described in reference to the center point 74. At least a portion of each of the petals 41 is located an equal distance away from the center point 74, and thus can be considered aligned around a first reference circle C1, as shown in
As shown in
As shown in
In at least one embodiment, the potential side branches 68 are aligned in a plurality of rows, as shown in
Additionally, this embodiment has non-perpendicular circumference rows of potential side branches 68 aligned along the A1A and A3B axes, as shown in
Note that the number of potential side branches 68 in a circumferential or longitudinal row depends upon the diameter of the stent 10, the size of the potential side branches 68, the distance between adjacent potential side branches 68, the longitudinal length of the section of the stent 10 containing the potential side branches 68 and any combination thereof.
A stent 10 which comprises a plurality of potential side branches 68 that each have the configuration, is shown in
Adjacent circumferential rows of first potential side branches 68a are engaged to a circumferential band 22 of struts 24 by connecting members 90. In this embodiment, two connecting members 90 engage each first potential side branch 68a to the circumferential band 22, however, it is within the scope of the invention for any number of connecting members 90 to engage a first potential side branch 68a to the circumferential band 22. Thus, the potential side branch 68 can be engaged to the circumferential band 22 by one, two, three, four, five, six, or more connecting members 90. Although the connecting member 90 in
In at least one embodiment, the struts 24 forming the circumferential band 22 have a plurality of discrete lengths, as shown, for example, in
In at least one embodiment, the side branch of the stent 10 is deployed using a balloon catheter 118. In this embodiment, the stent 10 is first deployed in the main vessel in a manner known in the art. Then a guide wire and balloon 100 are advanced through an opening in the stent 10 into the side branch vessel. In some embodiments, the balloon 100 is inflated to open the side branch 68. In other embodiments, the balloon 100 progressively inflates from the proximal end to the distal end thereby deploying the side branch 68. In
A progressively inflatable balloon 100 can be formed, for example, by the use of specific fording techniques that control inflation (i.e., proximal to distal, distal to proximal, inside out, outside in, etc.); by gradient extrusion or intermittent layer coextrusion (ILC) techniques; variable heat formation of the balloon 100; or by variable wall thickness extrusions or molding of the balloon 100. In at least one embodiment, variable heat setting is used to produce a progressively inflatable balloon 100. In some embodiments, the balloon 100 is heat set into the folded configuration with more heat being applied at the proximal end of the balloon 100 than the distal end of the balloon 100. In this embodiment, the proximal end of the balloon 100 is stiffer than the distal end of the balloon 100 which causes the distal end of the balloon 100 to inflate before the proximal end of the balloon 100. In at least one embodiment, the balloon 100 has variable wall thickness with the proximal end of the balloon 100 having a thicker wall than the distal end of the balloon 100. In some embodiments, the variable wall thickness of the balloon 100 is produced by extrusion. In other embodiments, the variable wall thickness is produced by molding.
In at least one embodiment, the stent 10 is deployed in a body lumen using a balloon catheter 118 where the balloon 100 is a dual lumen balloon 100. Although the dual lumen balloon 100 is described in reference to a stent 10 to be deployed at a bifurcation, it the dual lumen balloon 100 can be used to deploy any type of stent/bifurcated stent 10, including but not limited to, stents 10 with auxetic stent geometry and stents 10 with self flaring designs.
As shown in
In at least one embodiment, the inner balloon 100a and/or the outer balloon 100b has at least one channel molded therein. Thus, in this embodiment, the inner balloon 100a has channels molded on its exterior surface and/or the outer balloon 100b has at least one channel molded on its interior surface. In some embodiments, the channels allow unobstructed pressurization of the outer balloon 100b. A non-limiting example of a balloon with a channel molded in a surface is shown in
In at least one embodiment, the inner balloon 100a is made of a material that allows the inner balloon 100a to be inflated at a high nominal pressure. In some embodiments, the inner balloon 100a is made of a non-compliant material. Examples of non-compliant material include, but are not limited to, polyethylene terephthalates, polyacrylenesulfide, and copolyesters.
In some embodiments, the inner balloon 100a is a monolayer of polymer, i.e. the inner balloon 100a comprises one polymer layer. In other embodiments, the inner balloon 100a comprises a plurality of polymer layers. In at least one embodiment, the layering of the polymer is varied along the length of the inner balloon 100a. In some embodiments, the composition of the polymer varies along the length of the inner balloon 100a. In other embodiments, the treatment of the inner balloon 100a is varied along the longitudinal length of the inner balloon 100a thereby varying the characteristics of the inner balloon 100a along the longitudinal length of the inner balloon 100a.
In at least one embodiment, the outer balloon 100b is made of a material that allows the outer balloon 100b to be inflated at a low nominal pressure. In some embodiments, the outer balloon 100b works at a pressure below that of the inner balloon 100a. In some embodiments, the outer balloon 100b is made of a compliant material Examples of compliant material include, but are not limited to, nylon, and polyamines. In other embodiments, the outer balloon 100b is made of a semi-compliant material. Examples of semi-compliant material include, but are not limited to, ethylene-vinyl acetate, polyvinyl chloride (PVC), olefin copolymers or homopolymers, polyethylenes, polyurethanes, crosslinked low density polyethylenes (PETs), highly irradiated linear low density polyethylene (LDPE), acrylonitrile polymers and copolymers, acrylonitrile blends and ionomer resins.
In some embodiments, the middle portion of the outer balloon 100b is constructed and arranged to be more compliant than either end portion. In some embodiments, the outer balloon 100b is a monolayer of polymer, i.e. the outer balloon 100b comprises one polymer layer. In other embodiments, the outer balloon 100b comprises a plurality of polymer layers. In at least one embodiment, the layering of the polymer is varied along the length of the outer balloon 100b. In some embodiments, the composition of the polymer varies along the length of the outer balloon 100b. In other embodiments, the treatment of outer balloon 100b is varied along the longitudinal length of the outer balloon 100b thereby varying the characteristics of outer balloon 100b along the longitudinal length of the outer balloon 100b. For example, as discussed above, the outer balloon 100b can be formed using variable heat, formed by gradient extrusion or intermittent layer coextrusion (ILC) techniques, or formed with a variable thickness wall.
The dual lumen balloon 100 can be manufactured in several ways. Note that with any of these manufacturing processes, the inner and outer balloons 100a,b are separate from one another, i.e. there is a space between the inner and outer balloons 100a,b, so that the two balloons 100a,b can be separately inflated by the inner inflation lumen 122 and the outer inflation lumen 126 respectively. Thus, the outer balloon 100b has a greater outer diameter than the inner balloon 100a in both balloons 100a,b are in an unexpanded state and when both balloons 100a,b are in an expanded or inflated state. In one embodiment, the inner and outer balloons 100a,b of the dual lumen balloon 100 each are fabricated using typical blow molding procedures and then subsequently threaded together. In another embodiment, the inner and outer balloons 100a,b are blow molded together with a nonstick or sacrifical layer between the inner and outer balloons 100a,b so that the inner and outer balloons 100a,b are separate balloons. In at least one embodiment, the inner and outer balloons 100a,b of the dual lumen balloon 10 are folded simultaneously using standard folding processes.
As briefly discussed above, a balloon catheter 118 with the dual lumen balloon 100 can be used to deliver the stent 10 to a bifurcation 110. When the stent 10 is at the bifurcation 110, the inner balloon 100a is inflated to a high nominal pressure. Expansion of the inner balloon 100a deploys the stent 10 in the main vessel 112, as shown in
After the inner balloon 100a has been inflated the outer balloon 100b is inflated to a low nominal pressure. Wherever the outer balloon 100b is not constrained by the main vessel 112, the outer balloon 100b distends/expands. Thus, when the dual lumen balloon catheter 118 is used at a bifurcation 110, at least a portion of the outer balloon 100b is distended when inflated with low pressure. Distension of the outer balloon 100b deploys at least one potential side branch(es) 68 into the side branch vessel(s) 114, as shown in
In some embodiments, the outer balloon 100b is molded smaller than the inflation size of the inner balloon 100a In this embodiment, a relief of pressure on both the inner and outer balloons 100a,b causes the outer balloon 100b to elastically collapse the inner balloon 100a. In some embodiments, the elastic collapse of the outer balloon 100b causes the balloon 100 to self-fold.
In at least one embodiment, the stent 10 is deployed in a body lumen using a balloon catheter where the balloon 100 has a plurality of protrusions or herniations 102. As used in this application, a protrusion or herniation 102 is a portion of the balloon 100 that is constructed and arranged to expand more than adjacent areas of the balloon 100. Some non-limiting examples balloons with protrusions or herniations are discussed in commonly assigned U.S. Pat. No. 6,258,099, entitled Stent Security Balloon/Balloon Catheter, and U.S. Patent Application Publication No 2005/0015108, entitled Catheter Balloon Systems and Methods, both of which are hereby incorporated in their entirety.
A non-limiting example of a balloon 100 with a plurality of protrusions 102 is shown in
When the stent 10 is delivered to a bifurcation site, the balloon 100 with the protrusions 102 is expanded. The amount of expansion of each of the protrusions 102 of the balloon 100 depends upon the position of the protrusion 102 relative to the ostium(s) of the side branch vessels. Thus, a protrusion 102 that is positioned next to an ostium of a side branch vessel will expand more than a protrusion 102 positioned next to the vessel wall because the vessel wall limits the expansion of the protrusion 102. A potential side branch 68 aligned with an ostium of a side branch vessel becomes a side branch 68 upon the expansion of the protrusion 102, which is able to expand to its fullest extent because a vessel wall is not preventing expansion of the protrusion 102, which deploys the side branch 68.
The deployment mechanism described above and the fact that the stent 10 has a plurality of potential side branches 68 and an equal number of protrusions 102 means that the stent 10 can be deployed at a bifurcation without the need for a second guidewire to align the side branch 68 with the ostium of the side branch vessel. In addition, because the wall of the vessel limits the expansion of the protrusions 102, the stent 10 can be used as a non-bifurcated stent 10.
In at least one embodiment, the balloon 100 comprises a compliant inner balloon 100a and a non compliant outer sheath 106 that has perforations. In this embodiment, the placement of the perforations can be tailored to the design of the stent 10 so that the perforations are aligned with the potential side branches 68. Examples of compliant and non-compliant materials are described above. When the balloon 100 is expanded, the diameter of the inner balloon 100a is constrained by the sheath 106, except at the perforations, where the inner balloon 100a extends through the perforations. Thus, when the inner balloon 100a is in an expanded state, the balloon 100 has a configuration similar to the balloon 100 shown in
The following numbered statements characterize at least one of the embodiments described above:
1. A stent, the stent having a tubular body comprising a first section, the first section comprising a plurality of expandable side branches abutting one another, the plurality of expandable side branches comprising a plurality of first side expandable branches and a plurality of second expandable side branches.
2. The stent of statement 1, the plurality of expandable first side branches having a first configuration and the plurality of expandable second side branches having a second configuration.
3. The stent of statement 2, the first configuration being different than the second configuration.
4. The stent of statement 2, the first configuration comprising a serpentine ring defining a side branch opening.
5. A stent, the stent having a tubular body comprising a first section, the first section comprising a first expandable side branch and a second expandable side branch, the first expandable side branch abutting the second expandable side branch.
6. The stent of statement 5, the first expandable side branch having a first configuration, the second expandable side branch having a second configuration, the first configuration being different than the second configuration.
7. A stent, the stent having a tubular wall defining at least two side branch openings, the at least two side branch openings being adjacent to one another and partially defined by at least one common member.
8. A stent, the stent having a tubular wall, the tubular wall defining an interested arrangement of at least two potential side branch openings.
The following numbered statements characterize at least one of the embodiments described above:
1. A stent, the stent having a tubular body, the tubular body having a wall, the wall having a first section comprising a plurality of serpentine rings and a plurality of connecting members, the plurality of connecting members engaging adjacent serpentine rings, the first section of the wall defining at least one first cell and at least one second cell, each of the at least one first cells being defined by one of the plurality of serpentine rings, each of the at least one second cells being defined by three of the plurality of connecting members and a portion of three of the plurality of serpentine rings.
2. The stent of statement 1, the at least one first cell having a center region, the center region having a plurality of secondary regions extending therefrom.
3. The stent of statement 4, each of the plurality of secondary regions having a trunk, a first arm and a second arm.
The following numbered statements characterize at least one of the embodiments described above:
1. A stent, the stent having a tubular body, the tubular body having a wall, the wall having a first section comprising a plurality of serpentine rings and a plurality of connecting members, the plurality of connecting members engaging adjacent serpentine rings, the first section of the wall defining a plurality of cells, the plurality of cells comprising at least one first cell and at least one second cell, each of the at least one first cells being defined by one of the plurality of serpentine rings, each of the at least one second cells being defined by three of the plurality of connecting members and a portion of three of the plurality of serpentine rings.
2. The stent of statement 1, the stent having a longitudinal axis, a first portion of the at least one second cells having a first orientation to the longitudinal axis, a second portion of the at least one second cells having a second orientation to the longitudinal axis, the first orientation opposite from the second orientation.
3. The stent of statement 1, the at least one second cells being arranged in at least one longitudinal row of the at least one second cells, the at least one second cells in a longitudinal row alternating between a first orientation and a second orientation.
4. The stent of statement 3, a connecting member partially defining two adjacent second cells.
5. The stent of statement 3, the plurality of serpentine rings being arranged in at least one longitudinal row, adjacent serpentine rings in a longitudinal row being engaged by a connecting member.
6. The stent of statement 5, the at least one longitudinal row comprising a first longitudinal row and a second longitudinal row, a serpentine ring of the first longitudinal row being engaged to a serpentine ring of the second longitudinal row by a first connecting member and a second connecting member.
7. The stent of statement 6, the first connecting member being at a first oblique angle to the longitudinal axis of the stent, the second connecting member being at a second oblique angle to the longitudinal axis of the stent.
8. The stent of statement 1, the stent having a longitudinal axis, the at least one second cells being arranged in circumferential rows, the at least one second cells in a circumferential row alternating between a first orientation and a second orientation, the circumferential rows being at an oblique angle to the longitudinal axis of the stent.
9. The stent of statement 8, a connecting member partially defining two adjacent second cells.
10. The stent of statement 8, the plurality of serpentine rings being arranged in at least one circumferential row, adjacent serpentine rings in a circumferential row being engaged by a connecting member.
11. The stent of statement 10, the at least one circumferential row comprising a first circumferential row and a second circumferential row, a serpentine ring of the first circumferential row being engaged to a serpentine ring of the second circumferential row by a first connecting member and a second connecting member.
12. The stent of statement 11, the first connecting member being at an oblique angle to the longitudinal axis of the stent, the second connecting member being horizontal to the longitudinal axis of the stent.
13. The stent of statement 8, the stent comprising at least two circumferential rows of first and second cells, each circumferential row comprising at least one unit of cells.
14. The stent of statement 13, each unit of the at least one unit of cells comprising:
the first cell adjacent to the second cell opening in the first orientation, the second cell in the first orientation being adjacent to the second cell in the second orientation.
15. The stent of statement 14, the at least one unit of cells comprising a first unit and a second unit, the first cell of the first unit being adjacent to the second cell in the second orientation of the second unit.
16. The stent of statement 13, the at least two circumferential rows of cells comprising:
the first cell of a first unit of the first circumferential row of cells being circumferentially offset from the first cell of a first unit of the second circumferential row of cells.
The following numbered statements characterize at least one of the embodiments described above:
1. A stent, the stent having a tubular body, the tubular body having a wall, the wall having a first section comprising a plurality of serpentine rings and a plurality of connecting members, the plurality of connecting members engaging adjacent serpentine rings, the first section of the wall defining at least one first cell and at least one second cell, each of the at least one first cells being defined by one of the plurality of serpentine rings, each of the at least one second cells being defined by three of the plurality of connecting members and a portion of three of the plurality of serpentine rings.
2. The stent of statement 1, each of the plurality of serpentine rings comprising a plurality of first petals.
3. The stent of statement 2, each of the plurality of connecting members being engaged to one of the plurality of first petals, each first petal having only one connecting member engaged thereto.
4. The stent of statement 2, adjacent first petals engaged by a linking member.
5. The stent of statement 4, the linking member comprising a plurality of struts and a plurality of turns.
6. The stent of statement 5, the plurality of turns comprising at least one inner turn and at least one outer turn.
7. The stent of statement 6, each of the at least one first cells having a center point, the at least one inner turn comprising a first inner turn and a second inner turn, each of the first inner turns being a first distance away from the center point, and each of the second inner turns being a second distance away from the center point.
8. The stent of statement 7, the second distance being greater than the first distance.
9. The stent of statement 8, each of the outer turns being a third distance away from the center point, the third distance being greater than the second distance.
10. The stent of statement 5, the plurality of struts comprising at least one first strut and at least one second strut.
11. The stent of statement 10, the at least one first strut having at least one bend.
12. The stent of statement 10, adjacent first struts being mirror images.
13. The stent of statement 1, each of the plurality of serpentine rings comprising a plurality of sections, each section comprising:
a first end the first petal being engaged to a first end of the primary first strut, a second end of the primary first strut being engaged to a first end of the primary outer turn, a second end of the primary outer turn being engaged to a first end of the primary second strut, a second end of the primary second strut being engaged to a first end of the primary inner turn, a second end of the primary inner turn being engaged to a first end of the secondary second strut, a second end of the secondary second strut being engaged to a first end of the secondary outer turn, a second end of the secondary outer turn being engaged to a first end of the secondary first strut.
14. The stent of statement 13, adjacent sections being arranged so that a second end of the secondary first strut of a first section is engaged to a second end of a first petal of an adjacent section.
15. The stent of statement 1, each of the plurality of second cells comprising:
wherein each of the arms being defined by two second struts of one of the plurality of serpentine rings;
wherein the plurality of serpentine rings comprising a first serpentine ring, a second serpentine ring and a third serpentine ring, the plurality of connecting members comprising a first connecting member, a second connecting member and a third connecting member,
the third irregular shaped region being defined by the third connecting member, a primary strut of the third serpentine ring, a portion of a first outer turn of the third serpentine ring, a secondary first strut of the first serpentine ring, and a portion of a second outer turn of the first serpentine ring.
16. The stent of statement 1, the tubular wall defining a first flowpath, each of the plurality of serpentine rings having a deployed configuration, the serpentine ring in the deployed configuration forming a first side branch, the first side branch being at an oblique angle to the tubular wall, the first side branch defining a second flowpath, the second flowpath in fluid communication with the first flowpath.
17. The stent of statement 16, each of the three connecting members and three serpentine rings defining each of the at least one second cells having a deployed configuration, the three connecting members and three serpentine rings in the deployed configuration forming a second side branch, the second side branch being at an oblique angle to the tubular wall, the second side branch defining a third flowpath, the third flowpath in fluid communication with the first flowpath.
18. The stent of statement 17, the stent having at least one first side branch.
19. The stent of statement 18, the stent further having at least one second side branch.
20. The stent of statement 17, the stent having at least one second side branch.
The inventive stents may be made from any suitable biocompatible materials including one or more polymers, one or more metals or combinations of polymer(s) and metal(s). Examples of suitable materials include biodegradable materials that are also biocompatible. By biodegradable is meant that a material will undergo breakdown or decomposition into harmless compounds as part of a normal biological process. Suitable biodegradable materials include polylactic acid, polyglycolic acid (PGA), collagen or other connective proteins or natural materials, polycaprolactone, hylauric acid, adhesive proteins, co-polymers of these materials as well as composites and combinations thereof and combinations of other biodegradable polymers. Other polymers that may be used include polyester and polycarbonate copolymers. Examples of suitable metals include, but are not limited to, stainless steel, titanium, tantalum, platinum, tungsten, gold and alloys of any of the above-mentioned metals. Examples of suitable alloys include platinum-iridium alloys, cobalt-chromium alloys including Elgiloy and Phynox, MP35N alloy and nickel-titanium alloys, for example, Nitinol.
The inventive stents may be made of shape memory materials such as superelastic Nitinol or spring steel, or may be made of materials which are plastically deformable. In the case of shape memory materials, the stent may be provided with a memorized shape and then deformed to a reduced diameter shape. The stent may restore itself to its memorized shape upon being heated to a transition temperature and having any restraints removed therefrom.
The inventive stents may be created by methods including cutting or etching a design from a tubular stock, from a flat sheet which is cut or etched and which is subsequently rolled out or from one or more interwoven wires or braids. Any other suitable technique which is known in the art or which is subsequently developed may also be used to manufacture the inventive stents disclosed herein.
In some embodiments the stent, the delivery system or other portion of the assembly may include one or more areas, bands, coatings, members, etc. that is (are) detectable by imaging modalities such as X-Ray, MRI, ultrasound, etc. In some embodiments at least a portion of the stent and/or adjacent assembly is at least partially radiopaque.
In some embodiments the at least a portion of the stent is configured to include one or more mechanisms for the delivery of a therapeutic agent. Often the agent will be in the form of a coating or other layer (or layers) of material placed on a surface region of the stent, which is adapted to be released at the site of the stent's implantation or areas adjacent thereto.
A therapeutic agent may be a drug ox other pharmaceutical product such as non-genetic agents, genetic agents, cellular material, etc. Some examples of suitable non-genetic therapeutic agents include but are not limited to: anti-thrombogenic agents such as heparin, heparin derivatives, vascular cell growth promoters, growth factor inhibitors, Paclitaxel, etc. Where an agent includes a genetic therapeutic agent, such a genetic agent may include but is not limited to: DNA, RNA and their respective derivatives and/or components; hedgehog proteins, etc. Where a therapeutic agent includes cellular material, the cellular material may include but is not limited to: cells of human origin and/or non-human origin as well as their respective components and/or derivatives thereof. Where the therapeutic agent includes a polymer agent, the polymer agent may be a polystyrene-polyisobutylene-polystyrene triblock copolymer (SIBS), polyethylene oxide, silicone rubber and/or any other suitable substrate.
The above disclosure is intended to be illustrative and not exhaustive. This description will suggest many variations and alternatives to one of ordinary skill in this art. The various elements shown in the individual figures and described above may be combined or modified for combination as desired. All these alternatives and variations are intended to be included within the scope of the claims where the term “comprising” means “including, but not limited to”.
Further, the particular, features presented in the dependent claims can be combined with each other in other manners within the scope of the invention such that the invention should be recognized as also specifically directed to other embodiments having any other possible combination of the features of the dependent claims. For instance, for purposes of claim publication, any dependent claim which follows should be taken as alternatively written in a multiple dependent form from all prior claims which possess all antecedents referenced in such dependent claim if such multiple dependent format is an accepted format within the jurisdiction (e.g. each claim depending, directly from claim 1 should be alternatively taken as depending from all previous claims). In jurisdictions where multiple dependent claim formats are restricted, the following dependent claims should each be also taken as alternatively written in each singly dependent claim format which creates a dependency from a prior antecedent-possessing claim other than the specific claim listed in such dependent claim below.
This completes the description of the invention. Those skilled in the art may recognize other equivalents to the specific embodiment described herein which equivalents are intended to be encompassed by the claims attached hereto.
Number | Name | Date | Kind |
---|---|---|---|
4309994 | Grunwald | Jan 1982 | A |
4445892 | Hussein et al. | May 1984 | A |
4649914 | Kowalewski | Mar 1987 | A |
4769005 | Ginsburg et al. | Sep 1988 | A |
4774949 | Fogarty | Oct 1988 | A |
4896670 | Crittenden | Jan 1990 | A |
4905667 | Foerster et al. | Mar 1990 | A |
4906244 | Pinchuk et al. | Mar 1990 | A |
4935190 | Tennerstedt | Jun 1990 | A |
4994071 | MacGregor | Feb 1991 | A |
5037392 | Hillstead | Aug 1991 | A |
5053007 | Euteneuer | Oct 1991 | A |
5087246 | Smith | Feb 1992 | A |
5108414 | Enderle et al. | Apr 1992 | A |
5112900 | Buddenhagen et al. | May 1992 | A |
5147302 | Euteneuer et al. | Sep 1992 | A |
5163989 | Campbell et al. | Nov 1992 | A |
5209799 | Vigil | May 1993 | A |
5226887 | Farr et al. | Jul 1993 | A |
5306246 | Sahatijian et al. | Apr 1994 | A |
5318587 | Davey | Jun 1994 | A |
5342307 | Euteneuer et al. | Aug 1994 | A |
5342387 | Summers | Aug 1994 | A |
5348538 | Wang et al. | Sep 1994 | A |
5350361 | Tsukashima et al. | Sep 1994 | A |
5358475 | Mares et al. | Oct 1994 | A |
5387235 | Chuter | Feb 1995 | A |
5403340 | Wang et al. | Apr 1995 | A |
5447497 | Sogard et al. | Sep 1995 | A |
5456666 | Campbell et al. | Oct 1995 | A |
5456712 | Maginot | Oct 1995 | A |
5458572 | Campbell et al. | Oct 1995 | A |
5476471 | Shifrin et al. | Dec 1995 | A |
5478319 | Campbell et al. | Dec 1995 | A |
5487730 | Marcadis et al. | Jan 1996 | A |
5523092 | Hanson et al. | Jun 1996 | A |
5549552 | Peters et al. | Aug 1996 | A |
5550180 | Elsik et al. | Aug 1996 | A |
5556383 | Wang et al. | Sep 1996 | A |
5591228 | Edoga | Jan 1997 | A |
5607444 | Lam | Mar 1997 | A |
5609605 | Marshall et al. | Mar 1997 | A |
5609627 | Goicoechea et al. | Mar 1997 | A |
5613980 | Chauhan | Mar 1997 | A |
5617878 | Taheri | Apr 1997 | A |
5632762 | Myler | May 1997 | A |
5632763 | Glastra | May 1997 | A |
5632772 | Alcime et al. | May 1997 | A |
5636641 | Fariabi | Jun 1997 | A |
5669924 | Shaknovich | Sep 1997 | A |
5669932 | Fischell et al. | Sep 1997 | A |
5676697 | McDonald | Oct 1997 | A |
5683450 | Goicoechea et al. | Nov 1997 | A |
5697971 | Fischell et al. | Dec 1997 | A |
5707348 | Krogh | Jan 1998 | A |
5709713 | Evans et al. | Jan 1998 | A |
5718684 | Gupta | Feb 1998 | A |
5718724 | Goicoechea et al. | Feb 1998 | A |
5720735 | Dorros | Feb 1998 | A |
5728065 | Follmer et al. | Mar 1998 | A |
5746745 | Abele et al. | May 1998 | A |
5749825 | Fischell et al. | May 1998 | A |
5749890 | Shaknovich | May 1998 | A |
5755734 | Richter et al. | May 1998 | A |
5755735 | Richter et al. | May 1998 | A |
5755771 | Penn et al. | May 1998 | A |
5755773 | Evans et al. | May 1998 | A |
5755778 | Kleshinski | May 1998 | A |
5782906 | Marshall et al. | Jul 1998 | A |
5800520 | Fogarty et al. | Sep 1998 | A |
5810767 | Klein | Sep 1998 | A |
5824036 | Lauterjung | Oct 1998 | A |
5824040 | Cox et al. | Oct 1998 | A |
5827320 | Richter et al. | Oct 1998 | A |
5830182 | Wang et al. | Nov 1998 | A |
5833657 | Reinhardt et al. | Nov 1998 | A |
5843172 | Yan | Dec 1998 | A |
5851464 | Davila et al. | Dec 1998 | A |
5868776 | Wright | Feb 1999 | A |
5868777 | Lam | Feb 1999 | A |
5882334 | Sepetka et al. | Mar 1999 | A |
5891108 | Leone et al. | Apr 1999 | A |
5893887 | Jayaraman | Apr 1999 | A |
5906640 | Penn et al. | May 1999 | A |
5908448 | Roberts et al. | Jun 1999 | A |
5922020 | Klein et al. | Jul 1999 | A |
5922021 | Jang | Jul 1999 | A |
5951941 | Wang et al. | Sep 1999 | A |
5961548 | Shmulewitz | Oct 1999 | A |
5972017 | Berg et al. | Oct 1999 | A |
5972027 | Johnson | Oct 1999 | A |
6013054 | Jiun Yan | Jan 2000 | A |
6013055 | Bampos et al. | Jan 2000 | A |
6013091 | Ley et al. | Jan 2000 | A |
6017324 | Tu et al. | Jan 2000 | A |
6017363 | Hojeibane | Jan 2000 | A |
6030414 | Taheri | Feb 2000 | A |
6033380 | Butaric et al. | Mar 2000 | A |
6033434 | Borghi | Mar 2000 | A |
6033435 | Penn et al. | Mar 2000 | A |
6048361 | Von Oepen | Apr 2000 | A |
6056775 | Borghi et al. | May 2000 | A |
6059824 | Taheri | May 2000 | A |
6068655 | Seguin et al. | May 2000 | A |
6071285 | Lashinski et al. | Jun 2000 | A |
6071305 | Brown et al. | Jun 2000 | A |
6086611 | Duffy et al. | Jul 2000 | A |
6093203 | Uflacker | Jul 2000 | A |
6096070 | Ragheb et al. | Aug 2000 | A |
6096073 | Webster et al. | Aug 2000 | A |
6099497 | Adams et al. | Aug 2000 | A |
6113579 | Eidenschink et al. | Sep 2000 | A |
6117117 | Mauch | Sep 2000 | A |
6117156 | Richter et al. | Sep 2000 | A |
6123712 | Di Caprio et al. | Sep 2000 | A |
6123721 | Jang | Sep 2000 | A |
6126652 | McLeod et al. | Oct 2000 | A |
6129738 | Lashinski et al. | Oct 2000 | A |
6129754 | Kanesaka et al. | Oct 2000 | A |
6135982 | Campbell | Oct 2000 | A |
6142973 | Carleton et al. | Nov 2000 | A |
6143002 | Vietmeier | Nov 2000 | A |
6146356 | Wang et al. | Nov 2000 | A |
6159238 | Killion et al. | Dec 2000 | A |
6165195 | Wilson et al. | Dec 2000 | A |
6168621 | Vrba | Jan 2001 | B1 |
6171278 | Wang et al. | Jan 2001 | B1 |
6183509 | Dibie | Feb 2001 | B1 |
6190404 | Palmaz et al. | Feb 2001 | B1 |
6203568 | Lombardi et al. | Mar 2001 | B1 |
6206915 | Fagan et al. | Mar 2001 | B1 |
6206916 | Furst | Mar 2001 | B1 |
6210380 | Mauch | Apr 2001 | B1 |
6210429 | Vardi et al. | Apr 2001 | B1 |
6210433 | Larre | Apr 2001 | B1 |
6210436 | Weadock | Apr 2001 | B1 |
6217503 | Weinberger | Apr 2001 | B1 |
6231598 | Berry et al. | May 2001 | B1 |
6240616 | Yan | Jun 2001 | B1 |
6241762 | Shanley | Jun 2001 | B1 |
6253443 | Johnson | Jul 2001 | B1 |
6254593 | Wilson | Jul 2001 | B1 |
6254632 | Wu et al. | Jul 2001 | B1 |
6258099 | Mareiro et al. | Jul 2001 | B1 |
6258115 | Dubrul | Jul 2001 | B1 |
6258116 | Hojeibane | Jul 2001 | B1 |
6258121 | Yang et al. | Jul 2001 | B1 |
6261305 | Marotta et al. | Jul 2001 | B1 |
6261316 | Shaolian et al. | Jul 2001 | B1 |
6261320 | Tam et al. | Jul 2001 | B1 |
6264662 | Lauterjung | Jul 2001 | B1 |
6264686 | Rieu et al. | Jul 2001 | B1 |
6273908 | Ndondo-Lay | Aug 2001 | B1 |
6273913 | Wright et al. | Aug 2001 | B1 |
6280413 | Clark et al. | Aug 2001 | B1 |
6287628 | Hossainy et al. | Sep 2001 | B1 |
6290673 | Shanley | Sep 2001 | B1 |
6293967 | Shanley | Sep 2001 | B1 |
6293968 | Taheri | Sep 2001 | B1 |
6325826 | Vardi et al. | Dec 2001 | B1 |
6328925 | Wang et al. | Dec 2001 | B1 |
6334864 | Amplatz et al. | Jan 2002 | B1 |
6334870 | Ehr et al. | Jan 2002 | B1 |
6346089 | Dibie | Feb 2002 | B1 |
6348065 | Brown et al. | Feb 2002 | B1 |
6355060 | Lenker et al. | Mar 2002 | B1 |
6358552 | Mandralis et al. | Mar 2002 | B1 |
6361544 | Wilson et al. | Mar 2002 | B1 |
6361555 | Wilson | Mar 2002 | B1 |
6379381 | Hossainy et al. | Apr 2002 | B1 |
6383213 | Wilson et al. | May 2002 | B2 |
6395018 | Castaneda | May 2002 | B1 |
6395020 | Ley et al. | May 2002 | B1 |
6395326 | Castro et al. | May 2002 | B1 |
6406457 | Wang et al. | Jun 2002 | B1 |
6409741 | Crocker et al. | Jun 2002 | B1 |
6423091 | Hojeibane | Jul 2002 | B1 |
6436104 | Hojeibane | Aug 2002 | B2 |
6436134 | Richter et al. | Aug 2002 | B2 |
6478816 | Kveen et al. | Nov 2002 | B1 |
6488653 | Lombardo | Dec 2002 | B1 |
6491666 | Santini, Jr. et al. | Dec 2002 | B1 |
6506437 | Harish et al. | Jan 2003 | B1 |
6508836 | Wilson et al. | Jan 2003 | B2 |
6517558 | Gittings et al. | Feb 2003 | B2 |
6520988 | Colombo et al. | Feb 2003 | B1 |
6527762 | Santini, Jr. et al. | Mar 2003 | B1 |
6527799 | Shanley | Mar 2003 | B2 |
6537256 | Santini, Jr. et al. | Mar 2003 | B2 |
6540779 | Richter et al. | Apr 2003 | B2 |
6551351 | Smith et al. | Apr 2003 | B2 |
6551838 | Santini, Jr. et al. | Apr 2003 | B2 |
6558422 | Baker et al. | May 2003 | B1 |
6562065 | Shanley | May 2003 | B1 |
6579309 | Loos et al. | Jun 2003 | B1 |
6579312 | Wilson et al. | Jun 2003 | B2 |
6582394 | Reiss et al. | Jun 2003 | B1 |
6596020 | Vardi et al. | Jul 2003 | B2 |
6599316 | Vardi et al. | Jul 2003 | B2 |
6638302 | Curcio et al. | Oct 2003 | B1 |
6645242 | Quinn | Nov 2003 | B1 |
6652441 | Weinberger et al. | Nov 2003 | B2 |
6656162 | Santini, Jr. et al. | Dec 2003 | B2 |
6669683 | Santini, Jr. et al. | Dec 2003 | B2 |
6689156 | Davidson et al. | Feb 2004 | B1 |
6692483 | Vardi et al. | Feb 2004 | B2 |
6695877 | Brucker et al. | Feb 2004 | B2 |
6706062 | Vardi et al. | Mar 2004 | B2 |
6709379 | Brandau et al. | Mar 2004 | B1 |
6713119 | Hossainy et al. | Mar 2004 | B2 |
6730064 | Ragheb et al. | May 2004 | B2 |
6749628 | Callol et al. | Jun 2004 | B1 |
6758859 | Dang et al. | Jul 2004 | B1 |
6764507 | Shanley et al. | Jul 2004 | B2 |
6773429 | Sheppard, Jr. et al. | Aug 2004 | B2 |
6776793 | Brown et al. | Aug 2004 | B2 |
6783543 | Jang | Aug 2004 | B2 |
6790228 | Hossainy et al. | Sep 2004 | B2 |
6811566 | Penn et al. | Nov 2004 | B1 |
6827250 | Uhland et al. | Dec 2004 | B2 |
6835203 | Vardi et al. | Dec 2004 | B1 |
6858038 | Heuser | Feb 2005 | B2 |
6884258 | Vardi et al. | Apr 2005 | B2 |
6896699 | Wilson et al. | May 2005 | B2 |
6904658 | Hines | Jun 2005 | B2 |
6932837 | Amplatz et al. | Aug 2005 | B2 |
6946092 | Bertolino et al. | Sep 2005 | B1 |
6955687 | Richter et al. | Oct 2005 | B2 |
6955688 | Wilson et al. | Oct 2005 | B2 |
6962602 | Vardi et al. | Nov 2005 | B2 |
6989071 | Kocur et al. | Jan 2006 | B2 |
7018400 | Lashinski et al. | Mar 2006 | B2 |
7041130 | Santini, Jr. et al. | May 2006 | B2 |
7052488 | Uhland | May 2006 | B2 |
7056323 | Mareiro et al. | Jun 2006 | B2 |
7056338 | Shanley et al. | Jun 2006 | B2 |
7060091 | Killion et al. | Jun 2006 | B2 |
7070616 | Majercak et al. | Jul 2006 | B2 |
7160321 | Shanley et al. | Jan 2007 | B2 |
7169175 | Cottone, Jr. et al. | Jan 2007 | B2 |
7169179 | Shanley et al. | Jan 2007 | B2 |
7179288 | Shanley | Feb 2007 | B2 |
7179289 | Shanley | Feb 2007 | B2 |
7208010 | Shanley et al. | Apr 2007 | B2 |
7208011 | Shanley et al. | Apr 2007 | B2 |
7220275 | Davidson et al. | May 2007 | B2 |
20010003161 | Vardi et al. | Jun 2001 | A1 |
20010004706 | Hojeibane | Jun 2001 | A1 |
20010004707 | Dereume et al. | Jun 2001 | A1 |
20010012927 | Mauch | Aug 2001 | A1 |
20010016766 | Vardi et al. | Aug 2001 | A1 |
20010016767 | Wilson et al. | Aug 2001 | A1 |
20010016768 | Wilson et al. | Aug 2001 | A1 |
20010025195 | Shaolian et al. | Sep 2001 | A1 |
20010027291 | Shanley | Oct 2001 | A1 |
20010027338 | Greenberg | Oct 2001 | A1 |
20010029396 | Wilson et al. | Oct 2001 | A1 |
20010037116 | Wilson et al. | Nov 2001 | A1 |
20010037138 | Wilson et al. | Nov 2001 | A1 |
20010039448 | Dibie | Nov 2001 | A1 |
20010049552 | Richter et al. | Dec 2001 | A1 |
20010056297 | Hojeibane | Dec 2001 | A1 |
20020013618 | Marotta et al. | Jan 2002 | A1 |
20020013619 | Shanley | Jan 2002 | A1 |
20020022874 | Wilson | Feb 2002 | A1 |
20020026232 | Marotta et al. | Feb 2002 | A1 |
20020035392 | Wilson | Mar 2002 | A1 |
20020038146 | Harry | Mar 2002 | A1 |
20020042650 | Vardi et al. | Apr 2002 | A1 |
20020052648 | McGuckin, Jr. et al. | May 2002 | A1 |
20020072790 | McGuckin, Jr. et al. | Jun 2002 | A1 |
20020091435 | Campbell | Jul 2002 | A1 |
20020095208 | Gregorich et al. | Jul 2002 | A1 |
20020111675 | Wilson | Aug 2002 | A1 |
20020156516 | Vardi et al. | Oct 2002 | A1 |
20020156517 | Perouse | Oct 2002 | A1 |
20020163104 | Motsenbocker et al. | Nov 2002 | A1 |
20020165604 | Shanley | Nov 2002 | A1 |
20020173835 | Bourang et al. | Nov 2002 | A1 |
20020173840 | Brucker et al. | Nov 2002 | A1 |
20020183763 | Callol et al. | Dec 2002 | A1 |
20020193872 | Trout, III et al. | Dec 2002 | A1 |
20020193873 | Brucker et al. | Dec 2002 | A1 |
20030009209 | Hojeibane | Jan 2003 | A1 |
20030028233 | Vardi et al. | Feb 2003 | A1 |
20030050688 | Fischell et al. | Mar 2003 | A1 |
20030055378 | Wang et al. | Mar 2003 | A1 |
20030055483 | Gumm | Mar 2003 | A1 |
20030074047 | Richter | Apr 2003 | A1 |
20030083687 | Pallazza | May 2003 | A1 |
20030093109 | Mauch | May 2003 | A1 |
20030097169 | Brucker | May 2003 | A1 |
20030105511 | Welsh et al. | Jun 2003 | A1 |
20030114912 | Sequin et al. | Jun 2003 | A1 |
20030125791 | Sequin et al. | Jul 2003 | A1 |
20030125802 | Callol et al. | Jul 2003 | A1 |
20030135259 | Simso | Jul 2003 | A1 |
20030163157 | McMorrow et al. | Aug 2003 | A1 |
20030167085 | Shanley | Sep 2003 | A1 |
20030181923 | Vardi | Sep 2003 | A1 |
20030195606 | Davidson et al. | Oct 2003 | A1 |
20030199970 | Shanley | Oct 2003 | A1 |
20040006381 | Sequin et al. | Jan 2004 | A1 |
20040015227 | Vardi et al. | Jan 2004 | A1 |
20040044396 | Clerc et al. | Mar 2004 | A1 |
20040059406 | Cully et al. | Mar 2004 | A1 |
20040068161 | Couvillon, Jr. | Apr 2004 | A1 |
20040073294 | Diaz et al. | Apr 2004 | A1 |
20040088007 | Eidenschink | May 2004 | A1 |
20040093071 | Jang | May 2004 | A1 |
20040117003 | Ouriel et al. | Jun 2004 | A1 |
20040122505 | Shanley | Jun 2004 | A1 |
20040122506 | Shanley et al. | Jun 2004 | A1 |
20040127976 | Diaz | Jul 2004 | A1 |
20040127977 | Shanley | Jul 2004 | A1 |
20040133268 | Davidson et al. | Jul 2004 | A1 |
20040138732 | Suhr et al. | Jul 2004 | A1 |
20040138737 | Davidson et al. | Jul 2004 | A1 |
20040142014 | Livack et al. | Jul 2004 | A1 |
20040143321 | Livack et al. | Jul 2004 | A1 |
20040143322 | Livack et al. | Jul 2004 | A1 |
20040148006 | Davidson et al. | Jul 2004 | A1 |
20040148012 | Jang | Jul 2004 | A9 |
20040172121 | Eidenschink et al. | Sep 2004 | A1 |
20040186560 | Alt | Sep 2004 | A1 |
20040202692 | Shanley et al. | Oct 2004 | A1 |
20040204750 | Dinh | Oct 2004 | A1 |
20040215227 | McMorrow et al. | Oct 2004 | A1 |
20040220661 | Shanley et al. | Nov 2004 | A1 |
20040225345 | Fischell et al. | Nov 2004 | A1 |
20040236408 | Shanley | Nov 2004 | A1 |
20040249449 | Shanley et al. | Dec 2004 | A1 |
20040267352 | Davidson et al. | Dec 2004 | A1 |
20050004656 | Das | Jan 2005 | A1 |
20050010278 | Vardi et al. | Jan 2005 | A1 |
20050015108 | Williams et al. | Jan 2005 | A1 |
20050015135 | Shanley | Jan 2005 | A1 |
20050043816 | Datta et al. | Feb 2005 | A1 |
20050060027 | Khenansho et al. | Mar 2005 | A1 |
20050096726 | Sequin et al. | May 2005 | A1 |
20050102017 | Mattison | May 2005 | A1 |
20050102019 | Yadin | May 2005 | A1 |
20050102021 | Osborne | May 2005 | A1 |
20050102023 | Yadin et al. | May 2005 | A1 |
20050119731 | Brucker et al. | Jun 2005 | A1 |
20050125076 | Ginn | Jun 2005 | A1 |
20050131526 | Wong | Jun 2005 | A1 |
20050149161 | Eidenschink et al. | Jul 2005 | A1 |
20050154442 | Eidenschink et al. | Jul 2005 | A1 |
20050154444 | Quadri | Jul 2005 | A1 |
20050183259 | Eidenschink et al. | Aug 2005 | A1 |
20050187602 | Eidenschink | Aug 2005 | A1 |
20050187611 | Ding et al. | Aug 2005 | A1 |
20050192657 | Colen et al. | Sep 2005 | A1 |
20050209673 | Shaked | Sep 2005 | A1 |
20050222668 | Schaeffer et al. | Oct 2005 | A1 |
20050228483 | Kaplan et al. | Oct 2005 | A1 |
20050273149 | Tran et al. | Dec 2005 | A1 |
20060015134 | Trinidad | Jan 2006 | A1 |
20060034884 | Stenzel | Feb 2006 | A1 |
20060036315 | Yadin et al. | Feb 2006 | A1 |
20060041303 | Israel | Feb 2006 | A1 |
20060045901 | Weber | Mar 2006 | A1 |
20060079956 | Eigler et al. | Apr 2006 | A1 |
20060088654 | Ding et al. | Apr 2006 | A1 |
20060093643 | Stenzel | May 2006 | A1 |
20060100686 | Bolduc et al. | May 2006 | A1 |
20060122698 | Spencer et al. | Jun 2006 | A1 |
20060173528 | Feld et al. | Aug 2006 | A1 |
20060206188 | Weber et al. | Sep 2006 | A1 |
20060287712 | Eidenschink | Dec 2006 | A1 |
20070005126 | Tischler | Jan 2007 | A1 |
20070050016 | Gregorich et al. | Mar 2007 | A1 |
20070055360 | Hanson et al. | Mar 2007 | A1 |
20070073376 | Krolik et al. | Mar 2007 | A1 |
20070073384 | Brown et al. | Mar 2007 | A1 |
20070100434 | Gregorich et al. | May 2007 | A1 |
20070173787 | Huang et al. | Jul 2007 | A1 |
20070173923 | Savage et al. | Jul 2007 | A1 |
20070225796 | Yadin | Sep 2007 | A1 |
20070270935 | Newhauser et al. | Nov 2007 | A1 |
20080172123 | Yadin | Jul 2008 | A1 |
Number | Date | Country |
---|---|---|
2220864 | Jul 1999 | CA |
9014845 | Feb 1991 | DE |
29701758 | Mar 1997 | DE |
29701883 | May 1997 | DE |
19921788 | Nov 2000 | DE |
0479730 | Oct 1991 | EP |
0565796 | Oct 1993 | EP |
0751752 | Jan 1997 | EP |
0783873 | Jul 1997 | EP |
0804907 | Nov 1997 | EP |
0479557 | Jul 1998 | EP |
0876805 | Nov 1998 | EP |
0880949 | Dec 1998 | EP |
0891751 | Jan 1999 | EP |
0895759 | Feb 1999 | EP |
0904745 | Mar 1999 | EP |
0937442 | Aug 1999 | EP |
0950386 | Oct 1999 | EP |
0347023 | Dec 1999 | EP |
1031328 | Aug 2000 | EP |
1031329 | Aug 2000 | EP |
0883384 | Dec 2000 | EP |
0862392 | Aug 2001 | EP |
0808140 | Dec 2001 | EP |
0884028 | Feb 2002 | EP |
1190685 | Mar 2002 | EP |
0897700 | Jul 2002 | EP |
0684022 | Feb 2004 | EP |
1157674 | Jul 2005 | EP |
1031330 | Nov 2005 | EP |
1070513 | Jun 2006 | EP |
2678508 | Jan 1993 | FR |
2740346 | Oct 1995 | FR |
2756173 | Nov 1996 | FR |
2337002 | May 1998 | GB |
8806026 | Aug 1988 | WO |
9423787 | Oct 1994 | WO |
9521592 | Aug 1995 | WO |
9629955 | Oct 1996 | WO |
9634580 | Nov 1996 | WO |
9641592 | Dec 1996 | WO |
9638109 | Dec 1996 | WO |
9707752 | Mar 1997 | WO |
9715346 | May 1997 | WO |
9716217 | May 1997 | WO |
9726936 | Jul 1997 | WO |
9741803 | Nov 1997 | WO |
9745073 | Dec 1997 | WO |
9746174 | Dec 1997 | WO |
9809670 | Mar 1998 | WO |
9819628 | May 1998 | WO |
9823228 | Jun 1998 | WO |
9836709 | Aug 1998 | WO |
9836784 | Aug 1998 | WO |
9837833 | Sep 1998 | WO |
9847447 | Oct 1998 | WO |
9848879 | Nov 1998 | WO |
9903426 | Jan 1999 | WO |
9904726 | Feb 1999 | WO |
9915103 | Apr 1999 | WO |
9915108 | Apr 1999 | WO |
9915109 | Apr 1999 | WO |
9923977 | May 1999 | WO |
9924104 | May 1999 | WO |
9929262 | Jun 1999 | WO |
9934749 | Jul 1999 | WO |
9936002 | Jul 1999 | WO |
9936015 | Jul 1999 | WO |
9944539 | Sep 1999 | WO |
9956661 | Nov 1999 | WO |
9965419 | Dec 1999 | WO |
0007523 | Feb 2000 | WO |
0010489 | Mar 2000 | WO |
0016719 | Mar 2000 | WO |
0027307 | May 2000 | WO |
0027463 | May 2000 | WO |
0028922 | May 2000 | WO |
0044307 | Aug 2000 | WO |
0044309 | Aug 2000 | WO |
0047134 | Aug 2000 | WO |
0048531 | Aug 2000 | WO |
0049951 | Aug 2000 | WO |
0051523 | Sep 2000 | WO |
0057813 | Oct 2000 | WO |
0067673 | Nov 2000 | WO |
0071054 | Nov 2000 | WO |
0071055 | Nov 2000 | WO |
0074595 | Dec 2000 | WO |
0117577 | Mar 2001 | WO |
0121095 | Mar 2001 | WO |
0121109 | Mar 2001 | WO |
0121244 | Mar 2001 | WO |
0126584 | Apr 2001 | WO |
0135715 | May 2001 | WO |
0135863 | May 2001 | WO |
0139697 | Jun 2001 | WO |
0139699 | Jun 2001 | WO |
0141677 | Jun 2001 | WO |
0143665 | Jun 2001 | WO |
0143809 | Jun 2001 | WO |
0145594 | Jun 2001 | WO |
0145785 | Jun 2001 | WO |
0149342 | Jul 2001 | WO |
0154621 | Aug 2001 | WO |
0154622 | Aug 2001 | WO |
0158385 | Aug 2001 | WO |
0160284 | Aug 2001 | WO |
0166036 | Sep 2001 | WO |
0170294 | Sep 2001 | WO |
0170299 | Sep 2001 | WO |
0174273 | Oct 2001 | WO |
0189409 | Nov 2001 | WO |
0191918 | Dec 2001 | WO |
0193781 | Dec 2001 | WO |
0200138 | Jan 2002 | WO |
02053066 | Jul 2002 | WO |
02068012 | Sep 2002 | WO |
03007842 | Jan 2003 | WO |
03055414 | Jul 2003 | WO |
03063924 | Aug 2003 | WO |
2004026174 | Apr 2004 | WO |
2004026180 | Apr 2004 | WO |
2005009295 | Feb 2005 | WO |
2005014077 | Feb 2005 | WO |
2005014077 | Feb 2005 | WO |
2005041810 | May 2005 | WO |
2005122959 | Dec 2005 | WO |
2006014631 | Feb 2006 | WO |
2006028925 | Mar 2006 | WO |
2006074476 | Jul 2006 | WO |
2006127127 | Nov 2006 | WO |
2007136637 | Nov 2007 | WO |
Entry |
---|
U.S. Appl. No. 60/844,011, filed Sep. 12, 2006; Inventor: Broome et al. |
U.S. Appl. No. 09/663,111, filed Sep. 15, 2000; Inventor: Davidson et al. |
U.S. Appl. No. 09/614,472, filed Jul. 11, 2000; Inventor: Davidson et al. |
U.S. Appl. No. 09/325,996, filed Jun. 4, 1999; Inventor: Vardi et al. |
Chevalier, M.D., Bernard, “Placement of Coronary Stents in Bifurcation Lesions by the “Culotte” Technique,” The American Journal of Cardiology, vol. 82, pp. 943-949 (Oct. 15, 1998). |
Nakamura M.D., Shigeru, “Techniques for Palmaz-Schatz Stent Deployment in Lesions with a Large Side Branch,” Catheterization and Cardiovascular Diagnosis, vol. 34, pp. 353-361 (1995). |
Caputo, Ronald P., “Stent Jail: A Minimum-Security Prison,” The American Journal of Cardiology, vol. 77, pp. 1226-1230 (Jun. 1, 1996). |
Colombo, M.D., Antonio, ““Kissing” Stent for Bifurcational Coronary Lesions,” Catheterization and Cardiovascular Diagnosis, vol. 30, pp. 327-330 (Dec. 1993). |
Carrie, M.D., Didier, ““T”-Shaped Stent Placement: A Technique for the Treatment of Dissected Bifurcation Lesions,” Catheterization and Cardiovascular Diagnosis, vol. 37 pp. 311-313 (Mar. 1996). |
Katoh, M.D., Osamu, “New Double Wire Technique to Stent Ostial Lesions,” Catheterization and Cardiovascular Diagnosis, vol. 40, pp. 400-402 (Apr. 1997). |
Lewis, M.D., Bruce E., “Acute procedural results in the treatment of 30 coronary artery bifurcation lesions with a double-wire atherectomy technique for side-branch protection,” American Heart Journal, vol. 127:6, pp. 1600-1607 (Jun. 1994). |
Yamashita, M.D., PhD., Takehiro, “Birfurcation Lesions: Two Stents Versus One Stent—Immediate and Follow-up Results,” Journal of the American College of Cardiology, vol. 35:5, pp. 1145-1151 (Apr. 2000). |
Satler, M.D., Lowell F., “Bifurcation Disease: To Treat or Not to Treat,” Catheterization and Cardiovascular Interventions, vol. 50, pp. 411-412 (2000). |
Number | Date | Country | |
---|---|---|---|
20090299460 A1 | Dec 2009 | US |